相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Methionine oxidation in -synuclein inhibits its propensity for ordered secondary structure
Erika Ponzini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
SMPD1 mutations, activity, and α-synuclein accumulation in Parkinson's disease
Roy N. Alcalay et al.
MOVEMENT DISORDERS (2019)
Histone serotonylation is a permissive modification that enhances TFIID binding to H3K4me3
Lorna A. Farrelly et al.
NATURE (2019)
O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease
Philip Ryan et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Nitrated alpha-synuclein in minor salivary gland biopsies in Parkinson's disease
Ling-Yan Ma et al.
NEUROSCIENCE LETTERS (2019)
α-Synuclein O-GlcNAcylation alters aggregation and toxicity, revealing certain residues as potential inhibitors of Parkinson's disease
Paul M. Levine et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
A Tango for Two: Dopamine and α-Synuclein Synergy May Explain Nigrostriatal Degeneration in Parkinson's Disease
Vivian Chen et al.
MOVEMENT DISORDERS (2018)
SUMOylation: One Small Modification for Proteins, Multiple Giant Problems for Mankind
Shweta Prasad et al.
MOVEMENT DISORDERS (2018)
Exploring the role of methionine residues on the oligomerization and neurotoxic properties of DOPAL-modified α-synuclein
Phelippe Carmo-Goncalves et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Dopamine System Dysregulation in Major Depressive Disorders
Pauline Belujon et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2017)
Dopamine dysregulation syndrome in Parkinson's disease: a systematic review of published cases
Nicola Warren et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Revisiting biomarker discovery by plasma proteomics
Philipp E. Geyer et al.
MOLECULAR SYSTEMS BIOLOGY (2017)
α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies
Yvette C. Wong et al.
NATURE MEDICINE (2017)
Synuclein and dopamine: the Bonnie and Clyde of Parkinson's disease
Subhojit Roy
NATURE NEUROSCIENCE (2017)
Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration
Danielle E. Mor et al.
NATURE NEUROSCIENCE (2017)
Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease
Lena F. Burbulla et al.
SCIENCE (2017)
Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson's disease
Hugo Vicente Miranda et al.
SCIENTIFIC REPORTS (2017)
Synaptic phosphorylated α-synuclein in dementia with Lewy bodies
Marti Colom-Cadena et al.
BRAIN (2017)
Toxic Dopamine Metabolite DOPAL Forms an Unexpected Dicatechol Pyrrole Adduct with Lysines of α-Synuclein
Jon W. Werner-Allen et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Munc 18-1 is a molecular chaperone for α-synuclein, controlling its self-replicating aggregation
Ye Jin Chai et al.
JOURNAL OF CELL BIOLOGY (2016)
Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
Sara Hall et al.
MOVEMENT DISORDERS (2016)
The Role of Dopamine and Its Dysfunction as a Consequence of Oxidative Stress
Hugo Juarez Olguin et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Monoaminylation of Fibrinogen and Glia-Derived Proteins: Indication for Similar Mechanisms in Posttranslational Protein Modification in Blood and Brain
Rene Hummerich et al.
ACS CHEMICAL NEUROSCIENCE (2015)
Oligomerization and Membrane-binding Properties of Covalent Adducts Formed by the Interaction of α-Synuclein with the Toxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde (DOPAL)
Cristian Follmer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Structure of the toxic core of α-synuclein from invisible crystals
Jose A. Rodriguez et al.
NATURE (2015)
Dopamine-induced α-synuclein oligomers show self- and cross-propagation properties
Matthew S. Planchard et al.
PROTEIN SCIENCE (2014)
Guanidine hydrochloride denaturation of dopamine-induced α-synuclein oligomers: A small-angle X-ray scattering study
Chi L. L. Pham et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2014)
Atomic force microscopy based nanoassay: a new method to study α-Synuclein-dopamine bioaffinity interactions
Stefania Corvaglia et al.
SCIENTIFIC REPORTS (2014)
Histaminylation of fibrinogen by tissue transglutaminase-2 (TGM-2): potential role in modulating inflammation
Thung-S Lai et al.
AMINO ACIDS (2013)
A Molecular Dynamics Simulation-Based Interpretation of Nuclear Magnetic Resonance Multidimensional Heteronuclear Spectra of α-Synuclein.Dopamine Adducts
Domenica Dibenedetto et al.
BIOCHEMISTRY (2013)
The interplay between lipids and dopamine on α-synuclein oligomerization and membrane binding
Chi L. L. Pham et al.
BIOSCIENCE REPORTS (2013)
Alpha-synuclein Post-translational Modifications as Potential Biomarkers for Parkinson Disease and Other Synucleinopathies
Adrien W. Schmid et al.
MOLECULAR & CELLULAR PROTEOMICS (2013)
The many faces of alpha-synuclein: from structure and toxicity to therapeutic target
Hilal A. Lashuel et al.
NATURE REVIEWS NEUROSCIENCE (2013)
A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease
Penelope G. Foulds et al.
SCIENTIFIC REPORTS (2013)
Oxidative Stress Effect of Dopamine on α-Synuclein: Electroanalysis of Solvent Interactions
Tiffiny Chan et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Histaminylation of glutamine residues is a novel posttranslational modification implicated in G-protein signaling
Jakob Vowinckel et al.
FEBS LETTERS (2012)
Transglutaminase-mediated transamidation of serotonin, dopamine and noradrenaline to fibronectin: Evidence for a general mechanism of monoaminylation
Rene Hummerich et al.
FEBS LETTERS (2012)
Mimicking Phosphorylation at Serine 87 Inhibits the Aggregation of Human α-Synuclein and Protects against Its Toxicity in a Rat Model of Parkinson's Disease
Abid Oueslati et al.
JOURNAL OF NEUROSCIENCE (2012)
Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers
He-Jin Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2011)
Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease
Penelope G. Foulds et al.
FASEB JOURNAL (2011)
Novel roles for biogenic monoamines: from monoamines in transglutaminase-mediated post-translational protein modification to monoaminylation deregulation diseases
Diego J. Walther et al.
FEBS JOURNAL (2011)
Dopamine quinones interact with a-synuclein to form unstructured adducts
Marco Bisaglia et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
The structure of dopamine induced α-synuclein oligomers
Agata Rekas et al.
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS (2010)
Interaction with synphilin-1 promotes inclusion formation of alpha-synuclein: mechanistic insights and pathological implication
Yuan-Yuan Xie et al.
FASEB JOURNAL (2010)
VPS41, a protein involved in lysosomal trafficking, is protective in Caenorhabditis elegans and mammalian cellular models of Parkinson's disease
Qingmin Ruan et al.
NEUROBIOLOGY OF DISEASE (2010)
Serotonin-more than a neurotransmitter: transglutaminase-mediated serotonylation of C6 glioma cells and fibronectin
Rene Hummerich et al.
NEUROCHEMISTRY INTERNATIONAL (2010)
Modulation of Alpha-Synuclein Aggregation by Dopamine Analogs
Diane Latawiec et al.
PLOS ONE (2010)
Modification of proteins by norepinephrine is important for vascular contraction
Kyle B. Johnson et al.
FRONTIERS IN PHYSIOLOGY (2010)
Formation of dopamine-mediated α-synuclein-soluble oligomers requires methionine oxidation
Su Ling Leong et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Dopamine and the Dopamine Oxidation Product 5,6-Dihydroxylindole Promote Distinct On-Pathway and Off-Pathway Aggregation of α-Synuclein in a pH-Dependent Manner
Chi L. L. Pham et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Cerebrospinal fluid α-synuclein in neurodegenerative disorders-A marker of synapse loss?
Annika Ohrfelt et al.
NEUROSCIENCE LETTERS (2009)
Inhibition of α-Synuclein Fibrillization by Dopamine Is Mediated by Interactions with Five C-Terminal Residues and with E83 in the NAC Region
Fernando E. Herrera et al.
PLOS ONE (2008)
Aggregation of α-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine
William J. Burke et al.
ACTA NEUROPATHOLOGICA (2008)
Cellular oligomerization of α-synuclein is determined by the interaction of oxidized catechols with a c-terminal sequence
Joseph R. Mazzulli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips
Juri Rappsilber et al.
NATURE PROTOCOLS (2007)
A case of dysferlinopathy presenting choreic movements
Toshiaki Takahashi et al.
MOVEMENT DISORDERS (2006)
Molecular-level secondary structure, polymorphism, and dynamics of full-length α-synuclein fibrils studied by solid-state NMR
H Heise et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Overview of the HUPO Plasma Proteome Project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database
GS Omenn et al.
PROTEOMICS (2005)
Reversible inhibition of α-synuclein fibrillization by dopaminochrome-mediated conformational alterations
EH Norris et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Structure and dynamics of micelle-bound human α-synuclein
TS Ulmer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Tissue transglutaminase-mediated formation and cleavage of histamine-gliadin complexes:: Biological effects and implications for celiac disease
SW Qiao et al.
JOURNAL OF IMMUNOLOGY (2005)
Serotonylation of small GTPases is a signal transduction pathway that triggers platelet α-granule release
DJ Walther et al.
CELL (2003)
Pathogenesis of Parkinson's disease:: Dopamine, vesicles and α-synuclein
J Lotharius et al.
NATURE REVIEWS NEUROSCIENCE (2002)
Activation of Pyk2/RAFTK induces tyrosine phosphorylation of α-synuclein via Src-family kinases
T Nakamura et al.
FEBS LETTERS (2002)
Dopamine-dependent neurotoxicity of α-synuclein:: A mechanism for selective neurodegeneration in Parkinson disease
J Xu et al.
NATURE MEDICINE (2002)
Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct
KA Conway et al.
SCIENCE (2001)
Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter
RE Whitehead et al.
JOURNAL OF NEUROCHEMISTRY (2001)
A hydrophobic stretch of 12 amino acid residues in the middle of α-synuclein is essential for filament assembly
BI Giasson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The role of NAC in amyloidogenesis in Alzheimer's disease
M Hashimoto et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
